Correlation Between Monte Rosa and Tcr2 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Tcr2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Tcr2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Tcr2 Therapeutics, you can compare the effects of market volatilities on Monte Rosa and Tcr2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Tcr2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Tcr2 Therapeutics.

Diversification Opportunities for Monte Rosa and Tcr2 Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Monte and Tcr2 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Tcr2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tcr2 Therapeutics and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Tcr2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tcr2 Therapeutics has no effect on the direction of Monte Rosa i.e., Monte Rosa and Tcr2 Therapeutics go up and down completely randomly.

Pair Corralation between Monte Rosa and Tcr2 Therapeutics

If you would invest (100.00) in Tcr2 Therapeutics on February 19, 2025 and sell it today you would earn a total of  100.00  from holding Tcr2 Therapeutics or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  Tcr2 Therapeutics

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Monte Rosa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in June 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Tcr2 Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tcr2 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Tcr2 Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Monte Rosa and Tcr2 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and Tcr2 Therapeutics

The main advantage of trading using opposite Monte Rosa and Tcr2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Tcr2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tcr2 Therapeutics will offset losses from the drop in Tcr2 Therapeutics' long position.
The idea behind Monte Rosa Therapeutics and Tcr2 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators